Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.79 +0.57 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Sales of Property, Plant and Equipment (2022)

Updated

Kiniksa Pharmaceuticals International (KNSA) reported Sales of Property, Plant and Equipment of $25,000 for FY2024.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Sales of Property, Plant and Equipment (2022) Analysis & Trends

  • According to Business Quant data, Sales of Property, Plant and Equipment came in at $91,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kiniksa Pharmaceuticals International 11.82 Bn 10.56 Bn 220.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 10,000.00
Sep 30, 2022 -10,000.00
API Access

Kiniksa Pharmaceuticals International Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=KNSA&period=max&api_key=YOUR_API_KEY